Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Radiodermatitis 3Head and Neck Neoplasms 3Hypotension 2Stroke 1Shock, Septic 1Optimal Tissue Perfusion 1Neoplasms 1Mouth Neoplasms 1Leiomyoma 1Brain Neoplasms 1Alopecia 1

Interventions

Nutrition Assessment 3Transcranial Direct Current Stimulation 2urinastatin 1tocilizumab 1rimabotulinumtoxinB 1X-Rays 1Vitamin B 6 1Vitamin B 12 1Thrombectomy 1Standard of Care 1Saline Solution 1Rosuvastatin Calcium 1Resistance Training 1Practice Guidelines as Topic 1Phenylephrine 1Palliative Care 1Norepinephrine 1Neuropsychological Tests 1Music Therapy 1Massage 1Lysine Acetyltransferase 5 1Infliximab 1Immunoglobulin G 1Hematologic Tests 1Folic Acid 1Extracorporeal Shockwave Therapy 1Exergaming 1Enoxaparin 1Disulfides 1Dialectical Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stroke × Norepinephrine × Clear all
NCT06711432 2024-12-02

PRECISION

Zhejiang Cancer Hospital

Phase NA Recruiting
214 enrolled

Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡